Background: It has been suggested that pancreaticogastrostomy (PG) is a safer reconstruction than pancreaticojejunostomy (PJ), resulting in lower morbidity, including lower pancreatic leak rates and decreased postoperative mortality. We com pared PJ and PG after pancreaticoduodenectomy (PD).
T he first pancreatic resections were performed more than 100 years ago. 1, 2 More specifically, 1stage pan creaticoduodenectomies (PD) have been performed since the 1930s. 1 But it wasn't until the early 1990s when a drop in mortality below 5% was reported in highvolume expert centres. 3, 4 Despite this, the procedure is still associ ated with substantial morbidity, owing mostly to problems related to the anastomosis between the pancreas and the gastrointestinal tract. Uncontrolled leak at this site is asso ciated with substantial complications that can start a down ward spiral of sepsis, multiorgan failure and even death. Consequently, multiple strategies have been implemented and researched in order to decrease this leak rate. 5 These include different suturing techniques; options for external and internal drainage; topical sealants; and pharmacologic prophylaxis, including octreotide. 6, 7 Another factor evalu ated is the luminal organ to which the pancreas is anasto mosed. The 2 main options are pancreaticojejunostomy (PJ) and pancreaticogastrostomy (PG).
Previously, mostly because of an absence of data resulting from prospective randomized trials, the choice of recon structive technique was largely institutionspecific. This is supported by a survey distributed among members of the Canadian HepatoPancreaticoBiliary Society that showed that 100% of the 20 highvolume pancreas surgeons across the country were using strictly PJ anastomosis (unpublished data, 2004) . In contrast, some centres, particu larly in Europe, preferred the option of PG anastomosis.
The theoretical advantages of PG reconstruction include the convenient location of the wellvascularized stomach; the lack of activation of pancreatic proenzymes theoretically decreasing morbidity, even in the case of a leak; and the option of relatively safe and easy drainage and control of the area with a nasogastric (NG) tube.
During the course of the present study, a number of other similar trials were published. [8] [9] [10] [11] [12] [13] [14] [15] Some of these com parisons have been summarized in recent systematic reviews and metaanalyses. [16] [17] [18] [19] [20] Observational studies sug gested that PG is a safer reconstruction than PJ, resulting in lower morbidity, including lower pancreatic leak rates and decreased postoperative mortality.
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Methods
Study design
This study was designed as a singlecentre randomized con trolled trial consisting of standard pretreatment assessment and a randomized treatment with either PG or PJ recon struction after a standard PD. The 2 arms received identical postoperative therapy. Neither participants, nor the health care providers were blinded to group assignment. The pri mary outcome was the rate of pancreatic anastomotic leak/ fistula, and the secondary outcomes were overall morbidity and mortality and length of stay in hospital. The trial pro tocol was publicly accessible at ClinicalTrials .gov with the identifier number NCT00841607. The study was con ducted from August 2006 to May 2012. Pancreatic leak/ fistula was defined as either radiologically proven anasto motic leak or continued drainage (via drain, enterocuta neous fistula or wound) of lipaserich fluid on postoperative day 10. The severity was then reclassified using the Interna tional Study Group of Pancreatic Fistula classification. 29 Postoperative morbidity was classified using the ClavienDindo system. 30 Randomization was performed in the operating room at the beginning of the case using sealed randomization enve lopes that were computer generated. Four hepato pancreatico biliary (HPB) surgeons performed the procedures.
Patients
Participation in the study was offered to adult patients (≥ 18 yr) with pancreatic or periampulary neoplasms in whom preoperative imaging and clinical status suggested resectable disease and in whom PD was planned. All par ticipants provided informed consent.
Patients younger than 18 years; adults unable to pro vide consent; patients with gastric involvement, metastatic disease or local unresectability; pregnant or nursing women; patients enrolled in other studies; and patients receiving radiation or chemotherapy during the perioper ative time period were excluded (patients in our institution who have resectable disease undergo resection without neoadjuvant therapy). Patients were able to withdraw their consent at any time before the surgery for any reason. The University of Calgary institutional review board approved our study protocol.
Intervention
As mentioned earlier, PJ reconstruction was the pre ferred method of all pancreatic surgeons in major centres across Canada, including all 4 HPB surgeons in Calgary who were involved in the present study. The surgeons adopted the technique for PG described by Bassi and colleagues. 31 In order to familiarize themselves with PG, the 4 surgeons learned the procedure by watching a step bystep instructional video from Dr. Bassi and subse quently performed 5 procedures together as a group before starting the trial.
A standard laparotomy was performed and resectabil ity was assessed. The texture of the pancreatic gland was assessed throughout the procedure by the staff surgeon. The texture was then recorded at the end of the case using a 5point scale (i.e., very soft, soft, average, hard, very hard). Similarly, the size of the pancreatic duct was recorded (in millimetres). After breaking the seal on the randomization envelope, in case of resectable tumours the procedure continued with a standard resection: either traditional PD (3 surgeons) or pyloruspreserving PD (1 surgeon). After that, reconstruction was per formed using standard techniques with the only variation being the method of pancreatic anastomosis: either a PJ or a PG was performed.
For PJ, a 2layer endtoside anastomosis (with a sepa rate ducttomucosa layer) was performed using an inter nal pancreatic duct stent in most cases. Surgeons were permitted slight technical differences in the techniques they developed throughout their careers; details regarding these differences were recorded. For PG, the pancreatic remnant was mobilized for at least 2 cm and then brought through a posterior gastrotomy and anastomosed in 2 lay ers to the posterior wall of the stomach (outer layer of pancreas to seromuscular of the stomach and inner layer of pancreas to full thickness gastric wall). In PG recon struction, an internal pancreatic duct stent is not used because the pancreas protrudes into the lumen of the stomach and there is no anastomosis of the duct. Use of a stent was considered only in case of a substantial kink of the usually soft gland as a result of this anastomosis.
Postoperative care was provided using a standardized order set to achieve homogeneity regardless of the arm in which the patient was randomly assigned. Individualization in terms of timing of removal of NG tubes and drains, use of octreotide or blood transfusions and progression of care was then based on regular assessment by the team. We analyzed the lipase level in fluid from external drains on postoperative day 3. The drains were removed if the fluid was not lipaserich. In case of lipaserich contents, the fluid was retested on postoperative day 10.
Sample size calculation
We performed a 2sample power calculation with equal variances and normal distribution based on a primary out come of a pancreatic fistula rate of 15% ± 10%, as sug gested in previous trials and reviews. 11, 16 We used a signifi cance threshold of p < 0.05 and a power of 0.9 to detect a clinically meaningful decrease in fistula rate by 5%. This calculation indicated that 85 patients were needed in each study arm for a total of 170 patients.
Early study termination
During the course of the trial, 2 of the participating sur geons lost clinical equipoise owing to personal experience with the 2 reconstruction techniques and to emerging results from other centres. The surgeons believed that continuing to offer PJ reconstruction to patients with very soft pancreases was not in the patients' best interest, and the surgeons refused to follow the arm to which the patients were randomly assigned. As a result, 4 patients crossed over from the PJ to the PG arm, and the study was prematurely stopped with only 98 patients enrolled.
Statistical methods
We performed an intention to treat analysis. We com pared continuous variables using the Student t test and categorical variables using the χ 2 test. Nonparametric data were compared using the Mann-Whitney U test. These analyses compared preoperative patient characteristics, intraoperative events and postoperative outcomes with a main focus on overall postoperative complications and overall pancreatic fistula rates.
It is well documented that pancreatic texture significantly influences rates of pancreatic fistulas and postoperative com plications. 16 We can also expect that higher American Soci ety of Anesthesiologists (ASA) scores on preoperative assess ment should predict postoperative complications. Based on face validity we performed age and sexadjusted logistic regression to identify the influence of these factors (ASA score, pancreatic texture, randomization to PJ reconstruc tion) on overall postoperative complications and overall pan creatic fistula rates. We dichotomized the pancreatic gland texture into soft (texture ratings 1 and 2) versus nonsoft (ratings 3-5) for these calculations. Both pancreatic gland texture and pancreatic duct size were previously validated predictors of pancreatic leak. 32 Because both factors assess a characteristic of the pancreatic gland, we selected only pan creatic gland texture for our calculation.
During the initial design of the study, the use of pancre atic duct stent was considered a characteristic of the recon struction. A stent was being used in the PJ anastomosis where ducttomucosa is one of the layers. In the PG reconstruction a stent was not going to be used because the anastomosis does not involve suturing the pancreatic duct. It is an anastomosis between the pancreatic capsule and the wall of the stomach. Owing to premature termination of the trial and variability in the use of a pancreatic duct stent in the PG group, this variable became a potentially impor tant confounder and was therefore included as a fourth variable in the multivariate analysis.
We considered results to be significant at p < 0.05, and we used STATA software version 12 (StataCorp) for all calculations. Results are reported as means ± standard devi ations or as numbers with percentages, as appropriate.
Results
Patient characteristics
As mentioned earlier, our trial was stopped before full recruitment was achieved. We initially recruited 162 pa tients, but 61 were excluded because they were found to have unresectable disease during the procedure and 3 more withdrew consent. Our study population included 98 patients, of whom 48 were randomly assigned to PG and 50 were assigned to PJ reconstruction. Seven patients in itially assigned to PG actually underwent PJ reconstruction: 4 whose glands were too stiff to mobilize sufficiently, 2 who had major artery anatomic variations preventing mobilization and 1 who had previous gastric surgery that had not been documented before the procedure. Similarly, 4 patients ini tially assigned to PJ underwent PG reconstruction owing to surgeon preference, as described in the Methods section. This crossover was due to loss of equipoise and resulted in us stopping the trial. As a result, 45 patients underwent PG and 53 underwent PJ reconstruction (Fig. 1) .
The median age of the study population was 66 ± 12 years. The most common symptom was jaundice (n = 68, 69%), followed by pain and weight loss (n = 53, 54%).
Intention to treat analysis
Comparison of patient characteristics between the PG and PJ groups (Table 1) did not reveal any significant differ ences in age; sex; presenting symptoms; or comorbidity burden, quantified using a Charlson score, CharlsonAge comorbidity index and preoperative ASA score. The only significant difference was in the rate of preoperative biop sies (27 [57%] patients in the PG group v. 17 [34%] in the PJ group, p = 0.020), but there was no difference in fre quency of overall preoperative biliary instrumentation.
Multiple intraoperative characteristics were also compared (Table 1) . There was no difference in dura tion of surgery, estimated blood loss, intraoperative complications, postoperative use of octreotide, need for blood transfusions or use of postoperative perianasto motic external drains between the groups (80.85% in the PG group v. 91.67% in PJ group, p = 0.13). The difference in pancreatic gland texture and percentage of soft pancreatic glands between the groups (52% v. 39%) was not significant. There were significant differ ences between PG and PJ reconstructions in terms of the length of mobilization of the pancreas (31 ± 15 mm in the PG group v. 18 ± 10 mm in the PJ group, t 87 = 4.55, p < 0.001) and the frequency in which a stent was left in the pancreatic duct (10 [22%] in the PG group v. 39 [83%] in the PJ group, χ 2 1 = 34.97, p < 0.001). The length of mobilization is considered a part of the par ticular reconstruction characteristic rather than an additional factor and therefore will always show a significant difference when comparing the 2 recon There was no difference in surgeon distribution between the groups (χ 2 3 = 7.02, p = 0.07). Owing to the rel atively small number of cases, we did not consider using operating surgeon as a variable, and we did not perform any comparisons among surgeons.
Our comparison of postoperative outcomes (Table 2 ) revealed no significant difference in length of stay in hospi tal, overall postoperative complications, overall pancreatic fistula rates or grades of pancreatic fistulas.
Age and sexadjusted logistic regression analyses were conducted for overall postoperative complications and overall fistula rates ( Table 3) . None of the factors were found to be predictive of overall postoperative complica tions. Most importantly, there was no difference between PJ and PG (odds ratio [OR] 1.00). In the model predict ing postoperative pancreatic fistula, only soft pancreatic gland was associated with significantly greater risk (OR 5.89, p = 0.003). Randomization to reconstruction was not significant (OR 0.57, p = 0.46).
discussion
As in the literature from other parts of the world, our study did not identify any significant difference in overall morbidity or mortality between PJ and PG reconstruc tion. Unlike several other centres that did identify statis tically lower rates of postoperative leaks with PG recon struction, we did not obtain such a result. We found that pancreatic gland texture and patient characteristics, such as age and sex, had greater influence on outcomes than the surgical technique used for reconstruction.
When mortality is already low, it is difficult to identify new surgical techniques that would substantially decrease these rates. Therefore, length of stay in hospital becomes an important characteristic of patient outcomes. We found no significant difference in length of stay between the groups. As PG was a new technique for the surgeons involved in the present study, it is possible that later NG tube removal and slower progress in postoperative advancement in the PG group early in the study may have affected length of stay. That could also explain the relatively large standard deviation in the PG group. Their length of stay may seem excessive for surgeons practising in the United States, but this is standard length of stay in the Canadian system.
Limitations
A major limitation of this study was the crossover between the PG and PJ groups. This is partly caused by the need for much more gland mobilization for PG reconstruction. Certain patients will therefore not be suitable candidates for this type of anastomosis, particu larly patients with very firm pancreatic glands and those with anatomic variations preventing safe mobilization. Surgeon preference was another reason for crossover to the PG group; furthermore, initial preference for the PJ anastomosis and initial relative unfamiliarity with PG anastomosis and learning curve could have influenced rates of overall postoperative complications, especially severe postoperative complications, in the early stages of the study. Owing to the relatively small number of patients in each arm, we did not compare early and late complications. Consequently, a learning curve phenom enon cannot be ruled out. Also, the potential problem with a singlecentre study is external validity. Finally, in terms of methods and statistical analyses, we were not able to consider the present study a randomized clinical trial owing to the crossover and premature termination of the trial. 
conclusion
Within the limitations of this study, we did not identify any difference in overall rates of pancreatic fistulas/leaks between PJ and PG reconstruction when comparing all patients undergoing a Whipple procedure. As predicted, we found that a soft pancreatic gland was associated with higher rates of all postoperative pancreatic fistulas/leaks. None of the factors we studied predicted overall postop erative complications. 
